Navigation Links
Mentice AB Announces Leadership Changes Within Its Worldwide Operations
Date:3/11/2008

GOTHENBURG, Sweden, March 11 /PRNewswire/ -- Mentice AB, a leading supplier of virtual reality based training applications within the field of medicine has recently appointed James Ruscoe as Chairman of the Board and Goran Malmberg as President and CEO of Mentice.

Mr. Ruscoe graduated from Oxford University and brings with him a vast array of experience in innovative technologies. He also serves as CEO and board member of several Swiss private and charitable foundations. Mr. Ruscoe is the former advisor to the Presidency of the European Commission on the competitive implications of innovation; to the Chairman of the European Round Table of Industrialists, Brussels; and to the Chairman of the Italian National Agency for Innovation, New Technologies and the Environment, Rome.

Mr. Malmberg, formerly a member of the Mentice board, has extensive sales and marketing experience from executive positions within the software industry and has held sales management and senior executive roles with international focus during the last 15 years.

"I am excited about joining Mentice which I personally feel is an innovative and progressive company in a market with considerable potential. My goal is to develop the company through further product development while enhancing our sales and marketing operations. We trust the industry will notice the result of these changes in the very near future as Mentice works to maintain its leadership position by broadening its presence throughout the worldwide VR marketplace," said Goran Malmberg.

About Mentice:

Mentice is a leader in medical simulation with approximately 600 installations worldwide, 100 validation studies and more than 30 issued and pending patents. Mentice's Family of Procedicus (TM) simulators focus on the area of minimally invasive surgery within the fields of endovascular, cardiovascular and neurological intervention, core skills training, laparoscopy and arthroscopy.

Website info: http://www.mentice.com

Release #31008


'/>"/>
SOURCE Mentice Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
2. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
3. Lilly Announces Termination of AIR Insulin Program
4. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
5. Spectral announces 2007 financial results
6. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
7. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
8. Senetek PLC Announces Appointments of Key Personnel
9. Iomai Announces Year-End 2007 Financial Results and Business Progress
10. Dragon announces new product launch; increase in annual production output capacity
11. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... the launch of the Supplyframe Design Lab . Located in Pasadena, Calif., ... the future of how hardware projects are designed, built and brought to market. ...
(Date:6/23/2016)... BEACH, Calif. , June 23, 2016  Blueprint ... new biological discoveries to the medical community, has closed ... co-founder Matthew Nunez . "We have ... us with the capital we need to meet our ... will essentially provide us the runway to complete validation ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
(Date:6/22/2016)... 22, 2016 Cell Applications, Inc. and ... to produce up to one billion human induced ... one week. These high-quality, consistent stem cells enable ... and spend more time doing meaningful, relevant research. ... high-volume manufacturing process that produces affordable, reliable HiPSC ...
Breaking Biology Technology:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):